U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
2649126491A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney DiseaseCompletedNo Results AvailableChronic Kidney Disease (CKD)|Type 2 Diabetes Mellitus (T2DM)|Healthy Subjects|Pharmacokinetics of ASP8232|Pharmacodynamics of ASP8232Drug: ASP8232|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02218099
2649226492Effectivity of Slackline-Training in PhysiotherapyRecruitingNo Results AvailableHealthy Volunteers|Persons With no Known Significant Health Problems (Http://Clinicalcenter.Nih.Gov/Recruit/Volunteers.Html)Device: Slackline|Device: Wobbling Board|Device: Pre-training|Device: Fix visual anchor|Device: Moving visual anchor|Device: Post-traininghttps://ClinicalTrials.gov/show/NCT02218086
2649326493Pharmacokinetic Study of JNJ-42756493 in Healthy ParticipantsCompletedNo Results AvailableHealthyDrug: JNJ-42756493 10 mg tablet|Drug: JNJ-42756493 10 mg Oral Solution|Drug: JNJ-61818549https://ClinicalTrials.gov/show/NCT02218073
2649426494Coronary CT Angiography Using a Novel 3rd Generation Dual-Source CT SystemRecruitingNo Results AvailableCoronary Artery DiseaseProcedure: Coronary CT angiography on SOMATOM Force|Procedure: Previous coronary CT angiography on 2nd generation CT scannerhttps://ClinicalTrials.gov/show/NCT02218060
2649526495AOP2014 in Patients With Polycythemia Vera Who Previously Participated in the PROUD-PV Study.RecruitingNo Results AvailablePolycythemia VeraDrug: Pegylated-Proline-interferon alpha-2bhttps://ClinicalTrials.gov/show/NCT02218047
2649626496Safety, Tolerability and Pharmacokinetics of AGN-190168 in Subjects With Acne VulgarisCompletedNo Results AvailableAcne VulgarisDrug: AGN-190168 Formulation 1|Drug: AGN-190168 Formulation 2|Drug: tazarotene gel 0.1%|Drug: tazarotene cream 0.1%https://ClinicalTrials.gov/show/NCT02218034
2649726497A Study of the Abuse Liability Potential of Samidorphan in Healthy, Non-Dependent, Recreational Opioid UsersCompletedNo Results AvailableHealthy VolunteersDrug: Samidorphan|Drug: Placebo|Drug: Oxycodonehttps://ClinicalTrials.gov/show/NCT02218021
2649826498A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - FORWARD-5 StudyRecruitingNo Results AvailableMajor Depressive DisorderDrug: ALKS 5461|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02218008
2649926499Mindfulness-Based Cognitive Therapy in a Clinical Sample of OCD PatientsNot yet recruitingNo Results AvailableObsessive-Compulsive DisorderBehavioral: Mindfulness-Based Cognitive Therapy (MBCT)https://ClinicalTrials.gov/show/NCT02217995
2650026500Pilot Study to Assess Dimethyl Fumarate Related GI Symptom MitigationRecruitingNo Results AvailableRelapsing Remitting Multiple SclerosisDrug: Simethicone|Drug: Loperamide|Other: Peanut Butterhttps://ClinicalTrials.gov/show/NCT02217982
2650126501Prospective Trial of Alerting to Extended Hypotensive Exposures on Long-Term Outcome After SurgeryNot yet recruitingNo Results AvailableAnesthesia|HypotensionBehavioral: Electronic alert to SLUScore increasehttps://ClinicalTrials.gov/show/NCT02217969
2650226502Dose Escalation of Cisplatin Hyperthermic Intraperitoneal Chemotherapy After Surgery in Patients With Unresectable Stage IIIC Ovarian, Tube or Peritoneal Primary AdenocarcinomaRecruitingNo Results AvailableOvarian Adenocarcinoma|Fallopian Tube Adenocarcinoma|Primary Peritoneal CarcinomaDrug: Cisplatin|Drug: Bevacizumabhttps://ClinicalTrials.gov/show/NCT02217956
2650326503Prospective Metabolic Surgery in T2DM Chinese SubjectsRecruitingNo Results AvailableDiabetes|ObesityProcedure: Roux-en-Y gastric bypass|Procedure: Sleeve gastrectomyhttps://ClinicalTrials.gov/show/NCT02217943
2650426504Study to Evaluate the Effect Of WCK 2349 on the QT/QTc Interval in Health VolunteersRecruitingNo Results AvailableQt Interval, Variation inDrug: WCK 2349|Drug: Placebo|Drug: Moxifloxacinhttps://ClinicalTrials.gov/show/NCT02217930
2650526505Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous Rivipansel With rHuPH20 in Healthy SubjectsNot yet recruitingNo Results AvailableHealthyDrug: Rivipansel|Drug: Placebo|Drug: Rivipansel|Drug: Rivipansel|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02217917
2650626506A Study of MK-8591 in Anti-Retroviral Therapy-Naive, Human Immunodeficiency Virus-1 Infected Participants (MK-8591-003)Not yet recruitingNo Results AvailableHIV-1Drug: 10 mg MK-8591|Drug: 100 mg MK-8591|Drug: - https://ClinicalTrials.gov/show/NCT02217904
2650726507IFACT: Incidental Findings in Advanced Cancer TherapyEnrolling by invitationNo Results AvailableBreast Cancer|Colorectal Cancer|Bladder Cancer|Lung CancerBehavioral: Semi-structured interviewhttps://ClinicalTrials.gov/show/NCT02217891
2650826508Influence of Morphine on Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients With Acute Myocardial InfarctionRecruitingNo Results AvailableST-segment Elevation Myocardial Infarction|Non-ST-segment Elevation Myocardial Infarction|VA Drug Interactions [VA Drug Interaction]Drug: Morphine|Drug: Placebo|Drug: Ticagrelorhttps://ClinicalTrials.gov/show/NCT02217878
2650926509Patient-Centered Risk Adjusted Surveillance After Curative Resection of Colorectal CancerRecruitingNo Results AvailableColorectal CancerBehavioral: Interviews - Colorectal Cancer Participants|Behavioral: Questionnaire|Behavioral: Focus Groups|Behavioral: Interviews - Caregivers of Colorectal Cancer Participantshttps://ClinicalTrials.gov/show/NCT02217865
2651026510Treatment of Hypertension in Tibetan Adult PopulationNot yet recruitingNo Results AvailableHypertensionDrug: Nitrendipine|Drug: Hydrochlorothiazide|Drug: Captopril,Hydrochlorothiazide|Drug: Beijing hypotensive No.0https://ClinicalTrials.gov/show/NCT02217852
2651126511Multiple Ascending Dose Tolerability, Pharmacokinetic and Pharmacodynamic Study of DG3173CompletedNo Results AvailableHealthyDrug: DG3173|Drug: DG3173+Octreotide|Drug: Octreotide|Drug: DG3173 Placebo|Drug: DG3173 Placebo+Octreotide Placebo|Drug: Octreotide+DG3173 Placebohttps://ClinicalTrials.gov/show/NCT02217839
2651226512Single Dose Pharmacodynamic and Pharmacokinetic Study of DG3173CompletedNo Results AvailableHealthyDrug: DG3173|Drug: Saline|Drug: Octreotidehttps://ClinicalTrials.gov/show/NCT02217826
2651326513A Bioequivalence Study Comparing Two Different Tafamidis FormulationsCompletedNo Results AvailableHealthy VolunteersDrug: Tafamidis|Drug: Tafamidishttps://ClinicalTrials.gov/show/NCT02217813
2651426514The Effect of Subcutaneous Infusions of 3 Doses of DG3173 on Growth Hormone Levels in Untreated AcromegalicsActive, not recruitingNo Results AvailableAcromegalyDrug: saline|Drug: DG3173|Drug: octreotidehttps://ClinicalTrials.gov/show/NCT02217800
2651526515Food Effect Study for PF-06372865CompletedNo Results AvailableHealthyDrug: PF-06372865|Drug: PF-06372865https://ClinicalTrials.gov/show/NCT02217787
2651626516MGUIDE MORE Dental Implant Planning System- Clinical Accuracy StudyRecruitingNo Results AvailableFocus of Study: Computer-Aided Design/InstrumentationDevice: MGUIDE MOREhttps://ClinicalTrials.gov/show/NCT02217774
2651726517Pharmacokinetic Study in Patients Receiving Posaconazole Therapy in TaiwanEnrolling by invitationNo Results AvailablePharmacokinetics|Posaconazolehttps://ClinicalTrials.gov/show/NCT02217761
2651826518Name Generator Order Effects in Social NetworksRecruitingNo Results AvailableSocial InteractionOther: Survey questionnairehttps://ClinicalTrials.gov/show/NCT02217748
2651926519Expressive Writing for Individuals With Parkinson's Disease and Their CaregiversCompletedNo Results AvailableParkinson's Disease|Coping SkillsBehavioral: Writing Interventionhttps://ClinicalTrials.gov/show/NCT02217735
2652026520Use of the Ulcerative Colitis Diet for Induction of RemissionRecruitingNo Results AvailableUlcerative Colitis (UC)Other: Ulcerative Colitis Diet|Drug: Antibiotic cocktailhttps://ClinicalTrials.gov/show/NCT02217722

* Görseller ve İçerik tekif hakkına sahip olabilir